Funding Opportunities

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)

RFA-CA-19-020
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

RFA-CA-19-028
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)

RFA-CA-19-019
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)

RFA-CA-19-027
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)

RFA-CA-19-026
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

RFA-CA-19-025
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)

RFA-CA-19-024
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)

RFA-CA-19-023
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Notice of a Joint Veterans Health Administration/National Cancer Institute Data Science Initiative called the Big Data Scientist Training Enhancement Program (BD-STEP)

NOT-CA-19-034
Application Receipt Date: July 19, 2019

Revision Applications to NCI-supported R01 Awards to Include Research on the NCI's Provocative Questions (R01)

RFA-CA-17-019
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)

RFA-CA-18-019
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01)

RFA-CA-17-020
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)

RFA-CA-18-020
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01)

RFA-CA-17-021
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional)

RFA-CA-18-021
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50)

RFA-CA-17-022
Application Receipt Date: June 28, 2017, October 30, 2017, June 28, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional)

RFA-CA-18-022
Application Receipt Date: June 29, 2018, October 30, 2018

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional)

RFA-CA-18-023
Application Receipt Date: June 29, 2018, October 30, 2018